PsiQuantum and National Cancer Center Japan partner on quantum computing

{
  "signal_id": "e43808ad-543b-4ab6-9440-d77201f9d4fd",
  "signal_type": "news",
  "signal_subtype": "is_developing",
  "detected_at": "2026-03-13T10:05:51+00:00",
  "company": {
    "name": "PsiQuantum",
    "domain": "psiquantum.com"
  },
  "data": {
    "url": "https://www.pharmaceutical-technology.com/news/psiquantum-national-cancer-center-quantum-computing",
    "title": "PsiQuantum and National Cancer Center Japan partner on quantum computing",
    "excerpt": "PsiQuantum and National Cancer Center Japan partner on quantum computing.\n\nPsiQuantum will work with the National Cancer Center Japan to develop fault-tolerant algorithms and quantum applications.\n\nPsiQuantum and the National Cancer Center Japan have entered a collaborative research agreement to drive advancements in utility-scale quantum computing within drug discovery and oncology.\n\nThe partnership aims to investigate ways to implement quantum computing solutions throughout the healthcare value chain, with a focus on resource allocation, research and development, and patient outcomes in cancer care.\n\nWithin this collaboration, PsiQuantum will work with the National Cancer Center Japan to further fault-tolerant quantum algorithm development, as well as jointly develop clinically relevant quantum applications.\n\nThe initiative also involves other pharmaceutical companies in Japan. PsiQuantum's software suite, Construct, will be used during the partnership.\n\nConstruct is a secure platform built for designing, analysing, and optimising algorithms for fault-tolerant quantum computing.\n\nUtility-scale quantum computers are expected to enable chemically accurate molecular simulations with greater efficiency. This advancement could accelerate drug discovery processes, reduce research costs, and address real-world healthcare challenges.\n\nGlobalData Strategic Intelligence\n\nUS tariffs...",
    "product": "fault-tolerant algorithms and quantum applications",
    "summary": "PsiQuantum is developing fault-tolerant algorithms and quantum applications.",
    "category": "is_developing",
    "found_at": "2026-03-13T10:05:51Z",
    "planning": false,
    "image_url": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/PT-13-03-2026-shutterstock_2557731283.jpg",
    "confidence": 0.6991,
    "product_data": {
      "full_text": "fault-tolerant algorithms and quantum applications",
      "fuzzy_match": true
    },
    "product_tags": [
      "mobile",
      "online_technology"
    ],
    "published_at": "2026-03-13T10:05:51Z",
    "article_sentence": "PsiQuantum will work with the National Cancer Center Japan to develop fault-tolerant algorithms and quantum applications."
  }
}

curl https://signals.autobound.ai/v1/signals/e43808ad-543b-4ab6-9440-d77201f9d4fd \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"psiquantum.com","limit":20}'